Abbmira therapeutics is a Basel based biotech founded by experience scientists and entrepreneurs in September 2024. Abbmira develops first-in-class small molecules to fine-tune native immunity to treat difficult-to-treat cancers and chronic diseases.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2024
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in